BSEResult2d ago · 23 Oct 2026, 05:30 pm
Unaudited Financial results for quarter and half year ended September 30, 2026
Dr Reddys Laboratories Ltd · 500124
✦ AI SummaryResults
Dr Reddys Laboratories Ltd has announced unaudited financial results for the quarter and half year ended September 30, 2026, with the Board of Directors considering and approving various financial results and reports.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr Reddys Laboratories Ltd - 500124 - Unaudited Financial Results For Quarter And Half Year Ended September 30, 2026
Attachments (1)
📄pdf
Download →
e72859b1-fdd1-42fe-8a8f-5c3bb7c13d06.pdf
View document text
Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills
Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900
Fax: + 91 40 4900 2999
Email: mail@drreddys.com
Web: www.drreddys.com
October 23, 2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited. (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/Madam,
Sub: Unaudited Financial Results for the quarter and half-year ended September 30, 2026
Pursuant to Regulations 30 and 33 and other applicable provisions of Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) and in
furtherance to our letter dated September 22, 2026, we wish to inform you that the Board of Directors of the
Company, at their meeting held today, i.e. October 23, 2026, inter alia considered and approved the following:
a. Unaudited Consolidated Financial Results of the Company for the quarter and half-year ended
September 30, 2026, prepared in compliance with International Financial Reporting Standards (IFRS)
as issued by International Accounting Standards Board (IASB);
b. Press Release on Unaudited Financial Results of the Company for the quarter and half-year ended
September 30, 2026;
c. Unaudited Consolidated Financial Results of the Company for the quarter and half-year ended
September 30, 2026, as per Indian Accounting Standards (Ind AS);
d. Unaudited Standalone Financial Results of the Company for the quarter and half-year ended September
30, 2026, as per Indian Accounting Standards (Ind AS); and
e. Limited Review Reports of the Statutory Auditors on the aforesaid Unaudited Standalone and
Consolidated Financial Results as mentioned above.
The Board Meeting commenced at 3:00 p.m. IST and concluded at 4:38 p.m. IST.
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR
Encl: as above